A Prospective, Single-Arm, Multicenter 2-Phase Feasibility Study to Assess the TAXUS Petal Paclitaxel-Eluting Bifurcation Coronary Stent System (TAXUS Petal)for the Treatment of de Novo Atherosclerotic Bifurcation Lesions

Trial Profile

A Prospective, Single-Arm, Multicenter 2-Phase Feasibility Study to Assess the TAXUS Petal Paclitaxel-Eluting Bifurcation Coronary Stent System (TAXUS Petal)for the Treatment of de Novo Atherosclerotic Bifurcation Lesions

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms TAXUS-PETAL-I-FHU
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 25 Mar 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 11 Mar 2009 Planned number of patients changed from 60 to 28, according to clinicaltrials.gov.
    • 11 Mar 2009 Planned end date changed from 1 Dec 2012 to 1 Jun 2013, according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top